|
1
|
Shi J, Hua X, Zhu B, Ravichandran S, Wang
M, Nguyen C, Brodie SA, Palleschi A, Alloisio M, Pariscenti G, et
al: Somatic genomics and clinical features of lung adenocarcinoma:
A retrospective study. PLoS Med. 13:e10021622016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Consonni D, Pierobon M, Gail MH, Rubagotti
M, Rotunno M, Goldstein A, Goldin L, Lubin J, Wacholder S, Caporaso
NE, et al: Lung cancer prognosis before and after recurrence in a
population-based setting. J Natl Cancer Inst. 107:djv0592015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Balgkouranidou I, Liloglou T and Lianidou
ES: Lung cancer epigenetics: Emerging biomarkers. Biomarkers Med.
7:49–58. 2013. View Article : Google Scholar
|
|
5
|
Mehta A, Dobersch S, Romero-Olmedo AJ and
Barreto G: Epigenetics in lung cancer diagnosis and therapy. Cancer
Metastasis Rev. 34:229–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Robertson KD: DNA methylation and human
disease. Nat Rev Genet. 6:597–610. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Schöttker B, Ordóñez-Mena J,
Holleczek B, Yang R, Burwinkel B, Butterbach K and Brenner H: F2RL3
methylation, lung cancer incidence and mortality. Int J Cancer.
137:1739–1748. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tomizawa Y, Kohno T, Kondo H, Otsuka A,
Nishioka M, Niki T, Yamada T, Maeshima A, Yoshimura K, Saito R, et
al: Clinicopathological significance of epigenetic inactivation of
RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res.
8:2362–2368. 2002.PubMed/NCBI
|
|
9
|
Bjaanæs MM, Fleischer T, Halvorsen AR,
Daunay A, Busato F, Solberg S, Jørgensen L, Kure E, Edvardsen H,
Børresen-Dale AL, et al: Genome-wide DNA methylation analyses in
lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation
status, gene expression and prognosis. Mol Oncol. 10:330–343. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: The Gene Ontology Consortium: Gene Ontology: Tool for the
unification of biology. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate - A practical and powerful approach to
multiple testing. JR Stat Soc Ser A Stat Soc. 57:289–300. 1995.
|
|
12
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Raungrut P, Petjaroen P, Geater SL,
Keeratichananont W, Phukaoloun M, Suwiwat S and Thongsuksai P:
Methylation of 14-3-3σ gene and prognostic significance of 14-3-3σ
expression in non-small cell lung cancer. Oncol Lett. 14:5257–5264.
2017.PubMed/NCBI
|
|
14
|
Chagnon MJ, Uetani N and Tremblay ML:
Functional significance of the LAR receptor protein tyrosine
phosphatase family in development and diseases. Biochem Cell Biol.
82:664–675. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Soulières D, Hirsch FR, Shepherd FA,
Bordogna W, Delmar P, Shames DS and Klughammer B: PTPRF Expression
as a potential prognostic/predictive marker for treatment with
erlotinib in non-small-cell lung cancer. J Thorac Oncol.
10:1364–1369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu R, Levin AM, Kardia SLR and Cho KR:
Identification of novel amplicons in ovarian cancer using a
model-based scan statistic for identifying increased chromosomal
regions of gene expression. Cancer Res. 65:847. 2005.
|
|
17
|
Park J, Lee J and Choi C: Evaluation of
drug-targetable genes by defining modes of abnormality in gene
expression. Sci Rep. 5:135762015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Doldo E, Costanza G, Ferlosio A, Pompeo E,
Agostinelli S, Bellezza G, Mazzaglia D, Giunta A, Sidoni A and
Orlandi A: High expression of cellular retinol binding protein-1 in
lung adenocarcinoma is associated with poor prognosis. Genes
Cancer. 6:490–502. 2015.PubMed/NCBI
|
|
19
|
Napoli JL: Biosynthesis and metabolism of
retinoic acid: roles of CRBP and CRABP in retinoic acid: roles of
CRBP and CRABP in retinoic acid homeostasis. J Nutr. 123 Suppl
2:362–366. 1993.PubMed/NCBI
|
|
20
|
Doldo E, Costanza G, Ferlosio A, Passeri
D, Bernardini S, Scioli MG, Mazzaglia D, Agostinelli S, Del Bufalo
D, Czernobilsky B, et al: CRBP-1 expression in ovarian cancer: A
potential therapeutic target. Anticancer Res. 34:3303–3312.
2014.PubMed/NCBI
|
|
21
|
Gehring WJ and Hiromi Y: Homeotic genes
and the homeobox. Annu Rev Genet. 20:147–173. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hamada Ji, Omatsu T, Okada F, Furuuchi K,
Okubo Y, Takahashi Y, Tada M, Miyazaki YJ, Taniguchi Y, Shirato H,
et al: Overexpression of homeobox gene HOXD3 induces coordinate
expression of metastasis-related genes in human lung cancer cells.
Int J Cancer. 93:516–525. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ohta H, Hamada J, Tada M, Aoyama T,
Furuuchi K, Takahashi Y, Totsuka Y and Moriuchi T:
HOXD3-overexpression increases integrin alpha v beta 3 expression
and deprives E-cadherin while it enhances cell motility in A549
cells. Clin Exp Metastasis. 23:381–390. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Furuta J, Nobeyama Y, Umebayashi Y, Otsuka
F, Kikuchi K and Ushijima T: Silencing of peroxiredoxin 2 and
aberrant methylation of 33 CpG islands in putative promoter regions
in human malignant melanomas. Cancer Res. 66:6080–6086. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhong Z, Shan M, Wang J, Liu T, Xia B, Niu
M, Ren Y and Pang D: HOXD13 methylation status is a prognostic
indicator in breast cancer. Int J Clin Exp Pathol. 8:10716–10724.
2015.PubMed/NCBI
|
|
26
|
Shu Y, Wang B, Wang J, Wang JM and Zou SQ:
Identification of methylation profile of HOX genes in extrahepatic
cholangiocarcinoma. World J Gastroenterol. 17:3407–3419. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sánchez-Peña ML, Isaza CE, Pérez-Morales
J, Rodríguez-Padilla C, Castro JM and Cabrera-Ríos M:
Identification of potential biomarkers from microarray experiments
using multiple criteria optimization. Cancer Med. 2:253–265. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Castro M, Grau L, Puerta P, Gimenez L,
Venditti J, Quadrelli S and Sánchez-Carbayo M: Multiplexed
methylation profiles of tumor suppressor genes and clinical outcome
in lung cancer. J Transl Med. 8:862010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pinton P, Giorgi C, Siviero R, Zecchini E
and Rizzuto R: Calcium and apoptosis: ER-mitochondria
Ca2+ transfer in the control of apoptosis. Oncogene.
27:6407–6418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kurskii MD, Tugai VA and Fedoriv AN:
Effect of serotonin and calcium on separate components of
respiratory chain of mitochondria in some rabbit tissues). Ukr
Biokhim Zh. 42:584–588. 1970.(In Ukrainian). PubMed/NCBI
|
|
31
|
Xu X, Chen D, Ye B, Zhong F and Chen G:
Curcumin induces the apoptosis of non-small cell lung cancer cells
through a calcium signaling pathway. Int J Mol Med. 35:1610–1616.
2015. View Article : Google Scholar : PubMed/NCBI
|
